vs
IDEAYA Biosciences, Inc.（IDYA）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是BRC Group Holdings, Inc.的1.1倍（$207.8M vs $188.3M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 47.9%，领先9.4%）
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
IDYA vs RILY — 直观对比
营收规模更大
IDYA
是对方的1.1倍
$188.3M
净利率更高
IDYA
高出9.4%
47.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $207.8M | $188.3M |
| 净利润 | $119.2M | $90.3M |
| 毛利率 | — | 79.5% |
| 营业利润率 | 52.2% | 32.3% |
| 净利率 | 57.4% | 47.9% |
| 营收同比 | — | -21.9% |
| 净利润同比 | 330.1% | 1710.8% |
| 每股收益（稀释后） | $1.33 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDYARILY
| Q4 25 | — | $188.3M | ||
| Q3 25 | $207.8M | $215.3M | ||
| Q2 25 | — | $188.2M | ||
| Q1 25 | — | $197.2M | ||
| Q4 24 | — | $241.0M | ||
| Q3 24 | $0 | $225.5M | ||
| Q2 24 | $0 | $256.0M | ||
| Q1 24 | $0 | $263.4M |
净利润IDYARILY
| Q4 25 | — | $90.3M | ||
| Q3 25 | $119.2M | $91.1M | ||
| Q2 25 | — | $139.5M | ||
| Q1 25 | — | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $-51.8M | $-284.4M | ||
| Q2 24 | $-52.8M | $-433.6M | ||
| Q1 24 | $-39.6M | $-49.2M |
毛利率IDYARILY
| Q4 25 | — | 79.5% | ||
| Q3 25 | — | 83.7% | ||
| Q2 25 | — | 81.3% | ||
| Q1 25 | — | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | — | 82.1% | ||
| Q2 24 | — | 84.5% | ||
| Q1 24 | — | 85.3% |
营业利润率IDYARILY
| Q4 25 | — | 32.3% | ||
| Q3 25 | 52.2% | 30.4% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -31.2% | ||
| Q4 24 | — | -69.2% | ||
| Q3 24 | — | -36.4% | ||
| Q2 24 | — | -90.8% | ||
| Q1 24 | — | -6.1% |
净利率IDYARILY
| Q4 25 | — | 47.9% | ||
| Q3 25 | 57.4% | 42.3% | ||
| Q2 25 | — | 74.1% | ||
| Q1 25 | — | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | -126.1% | ||
| Q2 24 | — | -169.4% | ||
| Q1 24 | — | -18.7% |
每股收益（稀释后）IDYARILY
| Q4 25 | — | $2.78 | ||
| Q3 25 | $1.33 | $2.91 | ||
| Q2 25 | — | $4.50 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.60 | $-9.39 | ||
| Q2 24 | $-0.68 | $-14.35 | ||
| Q1 24 | $-0.53 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $786.9M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $1.1B | $-171.5M |
| 总资产 | $1.2B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IDYARILY
| Q4 25 | — | $226.6M | ||
| Q3 25 | $786.9M | $184.2M | ||
| Q2 25 | — | $267.4M | ||
| Q1 25 | — | $138.3M | ||
| Q4 24 | — | $146.9M | ||
| Q3 24 | $920.0M | $159.2M | ||
| Q2 24 | $701.7M | $236.9M | ||
| Q1 24 | $698.8M | $190.7M |
总债务IDYARILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDYARILY
| Q4 25 | — | $-171.5M | ||
| Q3 25 | $1.1B | $-260.5M | ||
| Q2 25 | — | $-351.7M | ||
| Q1 25 | — | $-496.8M | ||
| Q4 24 | — | $-488.2M | ||
| Q3 24 | $1.2B | $-497.6M | ||
| Q2 24 | $931.7M | $-218.3M | ||
| Q1 24 | $935.3M | $228.4M |
总资产IDYARILY
| Q4 25 | — | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | $973.7M | $3.2B | ||
| Q1 24 | $961.5M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.2M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $142.2M | — |
| 自由现金流率自由现金流/营收 | 68.4% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.19× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $13.5M | — |
8季度趋势，按日历期对齐
经营现金流IDYARILY
| Q4 25 | — | $26.2M | ||
| Q3 25 | $142.2M | $-60.6M | ||
| Q2 25 | — | $-25.6M | ||
| Q1 25 | — | $184.0K | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-49.2M | $19.5M | ||
| Q2 24 | $-32.9M | $111.5M | ||
| Q1 24 | $-43.8M | $135.4M |
自由现金流IDYARILY
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — |
自由现金流率IDYARILY
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度IDYARILY
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率IDYARILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | 1.19× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDYA
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
